Core Insights - Southbound funds increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 3.168 million shares on November 19, 2025, marking a 0.22% increase in total shares held [1][2] - Over the past five trading days, there have been four days of net increases in holdings, totaling 6.8563 million shares [1] - In the last twenty trading days, there were ten days of net increases, amounting to 9.4968 million shares [1] - As of now, southbound funds hold 1.453 billion shares of Jinxin Reproductive Medicine, representing 52.69% of the company's total issued ordinary shares [1] Company Overview - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and maternal and pediatric medical services [2] - Jinxin operates mainly in China and the United States, also engaging in the sale of medical consumables and equipment [2]
锦欣生殖（01951.HK）：11月19日南向资金增持316.8万股